retatrutide peptide from china People are buying unregulated, injectable peptides Chinese factories. Are they safe? Retatrutide (LY3437943) | GCGR/GLP-1R/GIPR Agonist

If you have questions or concerns about the substances you are taking, please consult your healthcare provider

According to the 2024 multi-society guidance from the ASA and other professional organizations, most patients can continue GLP-1 receptor agonists before elective procedures with appropriate risk assessment and mitigation strategies

NHS access requires meeting specific BMI and comorbidity criteria through NICE guidance, with prescription via specialist weight management services, though availability may be limited by supply constraints

Available as a $99 add-on or $298 standalone

GLP-1 receptor agonists: product information and regulatory guidance